A potential new treatment in development for multiple sclerosis created at QIMR Berghofer Medical Research Institute has secured a deal worth up to $63 million.
QIMR Berghofer attracts support for potential multiple sclerosis treatment
December 16, 2021 Australian Biotech
Latest Video
New Stories
-
Company rebates fall for the first time in years, lifting net PBS costs
October 27, 2026 - - Latest News -
Access delayed - the stakes are high for the industry's next agreements
October 27, 2026 - - Latest News -
Services Australia annual report confirms decline in prescription volume
October 27, 2026 - - Latest News -
CSL announces new chair as Brian McNamee prepares to bow out
October 26, 2026 - - Latest News -
Documents reveal net PBS spending set to remain on life support to the end of decade
October 26, 2026 - - Latest News -
PBS share of health spending on track to halve as Canberra prepares to negotiate with industry
October 26, 2026 - - Latest News -
There is an urgent need to reconsider the question of PBS sustainability
October 26, 2026 - - Latest News
